NCT05921435View on ClinicalTrials.gov

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 20, 2023

Primary Completion Date

September 1, 2023

Study Completion Date

September 15, 2023

Conditions
Hypertension
Interventions
DRUG

CKD-341, D958

A single dose of 1tablet under fasting condition

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY